课题基金 / 基金详情

Modulation of innate immune cells to create transplant tolerance

Modulation of innate immune cells to create transplant tolerance
调节先天免疫细胞以产生移植耐受
批准号：
8114471
负责人：
Xian Chang Li
金额：
$43.48万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-08-23 至 2011-07-31
来源：
https://reporter.nih.gov/project-details/8114471
关键词：
AddressAdverse effectsAffectAlloantigenAllogenicAllograftingAnimal ModelAreaAutoimmune DiseasesCell CommunicationCell Surface ReceptorsCell TransplantsCellsCessation of lifeChronicClinicComplexDataDendritic CellsDevelopmentEffector CellEquilibriumFrequenciesGerm LinesGoalsGraft RejectionGraft SurvivalImmuneImmune responseImmune systemImmunosuppressionImmunosuppressive AgentsInflammatoryKnowledgeLeadLifeMalignant NeoplasmsMediatingModelingNatural Killer CellsNatureOutcomePathway interactionsPatientsPharmaceutical PreparationsPlayProcessProtocols documentationRegulatory T-LymphocyteResearchRoleSiteSkinT-LymphocyteTechniquesTherapeutic InterventionTimeTransplant RecipientsTransplantationbasecancer therapycell typecytokinedesignend-stage organ failurein vivoinsightkillingsnovel therapeuticsprogramspublic health relevanceresponsetherapeutic development

项目成果

Xian Chang Li的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T cell fate decisions and transplant outcomes
T cell fate decisions and transplant outcomes
Control of Treg exhaustion by OX40
Control of dysfunctional Tregs
海外基金